Combination therapy against brain cancer proves effective in preclinical models

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could ...
C&EN

A targeted protein degrader that doubles as a cancer vaccine

The result is one molecule that can be both a checkpoint degrader and a cancer vaccine ( Nature 2026, DOI: 10.1038/s41586-025 ...

Brain cancer digital twin predicts treatment outcomes by mapping tumor metabolism

A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the ...
Morningstar

Radiant Biotherapeutics to Present New Data from Lead Oncology Program at SITC 2025 Annual Meeting

RBT-101, Radiant’s lead oncology program and 4-1BB agonist, demonstrated robust, durable and complete tumor regression without liver toxicity in MC38 colorectal mouse tumor model Poster presentation ...
The Stanford Daily

Stanford Cancer Institute features advancements in immunotherapy cancer treatments

In a Jan. 13th installation of the Stanford Cancer Institute’s “Breakthroughs in Cancer” lecture series, Lawrence Fong ...
Technology Networks

Brain Cancer Digital Twin Predicts Whether a Treatment Is Likely To Slow Tumor Growth

Researchers at the University of Michigan developed a machine learning–based digital twin to map real-time tumor metabolism ...